 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Sell: Avidity Biosciences Inc (RNA) President and CEO Sarah Boyce Sells 28,000 Shares

This indicator may be signaling RNA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Avidity Biosciences (RNA, $25.49) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

This is a signal that RNA's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Avidity Biosciences (RNA, $24.7) RSI Indicator left the overbought zone on March 27, 2024

This indicator may be signaling that RNA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Avidity Biosciences (RNA, $24.7) entered Downtrend as Momentum indicator drops below 0 level on Mar 27, 2024

Avidity Biosciences to Participate in Upcoming Investor Conferences Avidity Biosciences to Participate in Upcoming Investor Conferences PR Newswire SAN DIEGO, March 27, 2024 SAN DIEGO, March 27, 2024...

Avidity Biosciences to Participate in Upcoming Investor Conferences

Over the last three days, A.I.dvisor has detected that RNA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line...

Avidity Biosciences (RNA, $23.7) Aroon Indicator entered an Uptrend on March 22, 2024.

This is a Bearish indicator signaling RNA's price could decline from here. Traders may explore shorting the stock or put options...

Avidity Biosciences (RNA, $23.7) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 22, 2024

Avidity Biosciences (RNA, $23.7) RSI Indicator left the overbought zone on March 22, 2024

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, March...

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Avidity Biosciences (RNA, $24.24) Aroon Indicator entered an Uptrend on March 20, 2024.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Volume (M)	715,733.00
52-Wk High	$27.66
52-Wk Low	$4.83

RNA Avidity Biosciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals